Cite
HARVARD Citation
Maderer, A. et al. (2021). CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta oncologica. pp. 1543-1547. [Online].